55Indexed trials
mesh condition
Brain Diseases
Intelligence
Brain Diseases intelligence: 55 indexed trials, 16 recruiting studies, 52 sponsors across 41 countries.
16Recruiting
52Sponsors
41Countries
Leading sponsors
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.30 recruiting
Tammie L. S. Benzinger, MD, PhD21 recruiting
Azienda Sanitaria Universitaria Integrata del Trentino11 recruiting
Beijing Friendship Hospital10 recruiting
Chinese University of Hong Kong10 recruiting
Columbia University11 recruiting
Copenhagen University Hospital, Rigshospitalet11 recruiting
Comenius University11 recruiting
Danilo Toni10 recruiting
Eisai Co., Ltd.10 recruiting
Eisai Inc.10 recruiting
Beats Medical10 recruiting
Geographic activity
United States23trials
France11trials
Canada9trials
Spain7trials
Germany6trials
United Kingdom6trials
Poland5trials
Sweden5trials
Italy5trials
Belgium4trials
South Korea4trials
Finland4trials
Leading interventions
F 18 T8072trials
E20202trials
galantamine hydrobromide2trials
topiramate2trials
ACI-24.060 at Dose C in Study Part 21trials
ACI-24.060 with an additional adjuvant at Dose D in Study Part 1b1trials
ACI-24.060 at Dose B in Study Part 1a1trials
Anti-seizure medication1trials
ACI-24.060 at Dose C in Study Part 1a1trials
BGG4921trials
BPN147701trials
AFFITOPE® AD021trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.